OpenVSafe by OpenVAERS
Search V-safe

Q8Q-11127-13379

3 vaccinations 4 coded responses 25 check-ins 4 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
454 / OH
Registered
2021-03-24
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
8HZ-15111-89332 Child or adolescent in my care · Female · 2021-11-04

Timeline

  1. 2021-03-24
    Registered in v-safe
  2. 2021-03-24
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-24
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-03-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  5. 2021-03-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  6. 2021-03-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-02
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-04-07
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-14
    Dose 2 — Pfizer-BioNTech
  13. 2021-05-05
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-05-12
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-05-26
    Survey response — day 42, dose 2
    MedDRA: Abdominal pain upper, Menstrual disorder — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Persistent stomach pain. Abnormal period.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-10-15
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-11-02
    Dose 3 — Moderna
  18. 2021-11-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  19. 2021-11-05
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Chills, Fatigue or tiredness
    Free text: Swollen lymph nodes in armpit of left arm (injection side)
    MedDRA releases: 2024-11 · check-in free text available
  20. 2021-11-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  21. 2021-11-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  22. 2021-11-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  23. 2021-11-09
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  24. 2021-11-18
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  25. 2021-11-23
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  26. 2021-11-30
    Survey response — day 28, dose 3
    MedDRA: Malaise — Feeling: Poor · Be unable to do your normal daily activities
    Free text: General malaise.
    MedDRA releases: 2024-11 · check-in free text available
  27. 2021-12-07
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in
  28. 2021-12-14
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  29. 2022-02-01
    Survey response — 3 months, dose 3
    MedDRA: Heavy menstrual bleeding — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Heavy menstrual bleeding.
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-02-01
    Report sent to call center — 3 months, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  31. 2022-02-04
  32. 2022-02-09

Vaccinations

DoseDateManufacturerCo-administered
12021-03-24Pfizer-BioNTech
22021-04-14Pfizer-BioNTech
32021-11-02Moderna No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 8 — day 42, dose 2

2021-05-26

Symptoms: Persistent stomach pain. Abnormal period.

Release 10 — days 1–6 daily, dose 3

2021-11-05

Systemic reaction (other): Swollen lymph nodes in armpit of left arm (injection side)

Release 10 — day 28, dose 3

2021-11-30

Symptoms: General malaise.

Release 11 — 3 months, dose 3

2022-02-01

Symptoms: Heavy menstrual bleeding.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal pain upper ✓ ✓ ✓
SDHeavy menstrual bleeding · · ✓
SDMalaise · · ✓
SDMenstrual disorder ✓ ✓ ✓
SROLymphadenopathy · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…